IBA Lifesciences

High-cell-density Escherichia coli–based nanobody production: benchmarking of subcellular targeting, strain background and process development strategies

Abstract Background Nanobodies (NB) are compact single-domain antibody fragments with substantial diagnostic and therapeutic potential, but scalable microbial production under controlled bioreactor conditions remains insufficiently characterized. In this study a high-cell-density...